NCT00454363 2020-04-03Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerNational Cancer Institute (NCI)Phase 2 Completed52 enrolled 11 charts
NCT01204476 2016-07-15Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaNational Cancer Institute (NCI)Phase 1 Completed27 enrolled